Hepatic gastrointestinal stromal tumor: Systematic review of an exceptional location

Table 5 Outcome and follow-up in selected patients with EGIST of the liver

Ref.	Yr	Outcome	Follow-up (mo)
Hu et al[20]	2018	NA	NA
Joyon et al[21]	2018	Local recurrence (12 yr)	252
	2018	DF	18
Carrillo et al[22]	2017	DF	18
Lok et al[23]	2017	Brain metastasis (6 mo)	6
Cheng et al[24]	2016	DF	30
Nagai et al[25]	2016	DF	10
Liu et al[26]	2016	NA	NA
Wang et al[27]	2016	DF	12
Liu et al[28]	2016	Abdominal metastasis	17
Su et al[29]	2015	Progression of disease (died 6 mo)	6
Bhoy et al[3]	2014	DF	5
Lin et al[30]	2015	Hepatic recurrence (24 mo)	72
Mao et al[31]	2015	DF	12
Kim et al[32]	2014	NA	NA
Louis et al[33]	2014	DF	6
Zhou et al[34]	2014	DF	12
Li et al[35]	2012	NA	NA
Yamamoto et al[36]	2010	NA	NA
Luo et al[37]	2009	DF	3
Ochiai et al[38]	2009	Hepatic recurrence, submucosal gastric tumor (24 mo)	25
De Chiara et al[1]	2006	Lung mestastasis (14 mo)	39
Hu et al[6]	2003	Portal lymph node mestastasis (16 mo)	16

NA: Not available; DF: Disease free.